Multi Center Ulcerative Colitis Pediatric Pentasa Intervention Trial (MUPPIT). A Randomized, Single-blinded, Controlled, Parallel, Induction Therapy With Once vs. Twice Daily Dosing of Pentasa in Pediatric UC
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MUPPIT
- 07 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Dec 2014 Planned End Date changed from 1 Mar 2013 to 1 Jun 2015, as reported by ClinicalTrials.gov.
- 10 Dec 2014 Planned primary completion date changed from 1 Dec 2012 to 1 Mar 2015, as reported by ClinicalTrials.gov.